Application 216167
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPIRAMATE | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216167-001 | TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | 053a50430f4f… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216167-001 | AB1 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216167-001 | AB1 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216167-001 | AB1 | 1 | 053a50430f4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topiramate | TOPIRAMATE | Ajanta Pharma USA Inc. | 813f5fe2-df82-479c-8014-d503ff5df52b | 2026-03-24 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Aurobindo Pharma Limited | 32b48ea0-a215-43b8-83b4-a5435a686d68 | 2026-03-24 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Aurobindo Pharma Limited | d1588c37-9da9-4ccb-b78a-64234938a115 | 2026-03-24 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 5424d59e-74f1-4c3c-b737-79e9776e0b60 | 2026-03-23 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Trokendi XR | TOPIRAMATE | Supernus Pharmaceuticals, Inc. | 2dc7957e-a3e5-46bb-aa66-f3250f872f5e | 2026-03-20 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | be14624b-7eb9-4e7a-9274-1bb88270ecbe | 2026-03-16 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Camber Pharmaceuticals, Inc. | dbc52b16-b93d-4d83-942b-485c502db1fa | 2026-03-16 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Ascend Laboratories, LLC | 7bc4ec7a-9b83-4842-9057-e1a804b2596d | 2026-03-13 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Ascend Laboratories, LLC | 035bf713-1642-4215-83ec-0ed07c29f92c | 2026-03-13 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| Topamax | TOPIRAMATE | Janssen Pharmaceuticals, Inc. | 21628112-0c47-11df-95b3-498d55d89593 | 2026-03-12 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | C | 164cb1f7-1a41-675f-e063-6294a90ae0dd | 2026-03-05 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Advanced Rx of Tennessee, LLC | 4b1d3130-cf3c-d7da-e063-6294a90a6079 | 2026-02-18 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | A-S Medication Solutions | 7f1e4475-6326-47a3-a317-b04b74b7c109 | 2026-02-02 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | A-S Medication Solutions | 55e71f43-1cd5-4efc-9641-fda0a09c30f0 | 2026-02-02 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Dr. Reddys Laboratories Inc. | f07d81bc-5090-fbc5-2945-557cf002849c | 2026-02-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals Inc. | 68b22d22-c2d3-4e90-b302-56f7cb731427 | 2026-01-28 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | AvKARE | 25b377f7-ea89-fb56-e063-6394a90a239d | 2026-01-19 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | afd4c2b9-b80c-b43a-e053-2995a90ac923 | 2026-01-01 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Northwind Health Company, LLC | ca45d478-7214-5bc7-e053-2995a90aa601 | 2026-01-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Northwind Health Company, LLC | ae63e0e2-ceb1-4cc7-88fa-92cfa4516960 | 2026-01-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73990 | ORIG | 2023-04-14 |